Ventas - News Releases

December 16 - Ventas Announces Pricing for Joint Offering of Common Stock
December 3 - Ventas Appoints Richard Schweinhart SVP and CFO
December 3 - Ventas Announces Underwriters for Joint Offering of Common Stock
December 2 - Ventas to Commence Joint Offering of 16 Million Shares of Common Stock; Ventas to Cancel Merrill Lynch Presentation; Ventas to Comply With SFAS 144 to Reclassify Prior Years' Financial Statements
November 27 - Ventas To Present At Merrill Lynch Health Services Investor Conference
November 5 - Ventas Completes $120 Million Trans Healthcare Transaction
October 29 - Ventas Reports Third Quarter Normalized FFO of $0.37 Per Share; FFO Rises 32% Over Third Quarter 2001; Ventas Increases 2002 FFO Guidance to $1.35 - $1.36 Per Share
October 23 - Ventas Declares Regular Quarterly Dividend of $0.2375 Per Share; Ventas to Appear at CIBC Health Care Conference
October 11 - Ventas Comments On Kindred Announcement Regarding Professional Liability
October 8 - Ventas to Make $120 Million Investment With Trans Healthcare; Transaction Covers 27 Facilities in Ohio and Maryland
October 4 - Ventas to Issue Third Quarter Earnings and Hold Conference Call On October 29
September 19 - Ventas Names Raymond J. Lewis SVP and Chief Investment Officer
August 15 - Ventas Declares Regular Quarterly Dividend of $0.2375 Per Share
July 23 - Ventas to Extend Exchange Offer for Senior Notes
July 23 - Ventas Reports 2002 Second Quarter Normalized FFO of $0.33 Per Share; FFO Per Share Increases 22% Over Second Quarter 2001; Issues 2003 Guidance
June 28 - Executive Vice President Thompson Resigns From Ventas
June 24 - Ventas To Issue 2nd Quarter Earnings And Hold Conference Call On July 23; Ventas To Begin Exchange Offer Of Senior Notes
June 19 - Ventas Files $750 Million Universal Shelf Registration Statement
May 29 - Ventas to Participate at Annual NAREIT Institutional Investors Forum
May 14 - Ventas Declares Regular Quarterly Dividend of $0.2375 Per Share; Stockholders Elect Directors, Ratify E&Y at Annual Meeting
May 9 - Ventas Reports 2002 First Quarter FFO of $0.32 Per Diluted Share; FFO Per Share Increases 5% Over First Quarter 2001 and 15% Over Fourth Quarter 2001
May 6 - Ventas to Issue First Quarter Earnings and Hold Conference Call On May 9
April 17 - Ventas Closes Senior Note Offering and New Credit Facility, Issues Increased/Revised 2002 FFO Guidance; Company to Also Issue First Quarter Earnings and Hold Conference Call On May 9
April 12 - Ventas Prices $400 Million Of Senior Notes Due 2009 And 2012; Proceeds to be Used to Pay Down Debt
April 2 - Ventas To Offer $400 Million Of Senior Notes Due 2009 And 2012; Proceeds to be Used to Pay Down Debt
March 26 - Ventas Reports 2001 FFO of $1.13 Per Share
March 20 - Ventas to Issue 2001 Earnings and Hold Conference Call on March 26
February 12 - Ventas Declares Regular Quarterly Cash Dividend Of $0.2375 Per Share
January 29 - Ventas to Issue 2001 Earnings and Hold Conference Call On March 26; Ventas to Participate At UBS Warburg Healthcare Conference On February 5
January 2 - Ventas To Use Cash And Kindred Stock For 4th Quarter Dividend; Ventas Reduces Leverage And Cost Of Debt; DRIP To Be Available For 2002 Dividends; Thompson Promoted To Executive Vice President